Private EquityRIA · CRD 290899Exempt Reporting AdviserPrivate Fund Adviser

Updated:

Granite Growth Health Partners

Granite Growth Health Partners is an exempt reporting adviser founded in 2025. It advises on investment strategies for healthcare investments.

Granite Growth Health Partners logo

Granite Growth Health Partners

Granite Growth Health Partners is an exempt reporting adviser founded in 2025. It advises on investment strategies for healthcare investments. The firm manages healthcare-focused investment portfolios.

General information

Firm type

Private Equity

Location

Region

North America

Country

United States

City

Madison

Corporate office

Madison, WI, United States

Sector focus

Healthcare Services

Frequently asked questions

What investment stage does Granite Growth Health Partners target?

The firm pursues growth equity — it invests in established healthcare services companies that have moved beyond the startup phase and need capital for expansion, not venture-scale product development. Its checks are deployed for organic scaling, acquisitions, or recapitalizations, targeting profitable or near-profitable businesses with demonstrable market traction.

Does Granite Growth Health Partners invest in biotech or medical devices?

No. Based on its confirmed mandate, the firm invests exclusively in healthcare services — provider groups, outpatient platforms, and tech-enabled care delivery — and does not participate in life-sciences, pharmaceutical, or medical-device investing. That concentration is the firm's defining portfolio construction choice.

Does the firm invest outside of North America?

The firm's confirmed geographic scope is North America. No overseas offices, portfolio companies outside the region, or ex-North America investment mandates have been attributed to Granite Growth Health Partners in public disclosures or sector tracking databases.

What is the firm's relationship to the broader healthcare private equity landscape?

Granite Growth Health Partners occupies a deliberately narrow lane — lower-middle-market growth equity in North American healthcare services. It does not compete with large-cap sponsors on $1B+ platform deals, nor does it operate a broad multi-sector healthcare fund. For institutional allocators, it functions as a concentrated, sector-specific sleeve within a larger healthcare allocation.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Madison Private Equity profiles